Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine and Creatine in Duchenne Muscular Dystrophy
NCT00016653Phase 3Completed
- Sponsor
- Cooperative International Neuromuscular Research Group
- Start
- Jun 2000
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Glutamine, Creatine Monohydrate and Placebo (3 arms). Primary endpoint: Quantitative Muscle Strength Test at 6 months. Started Jun 2000; status: completed.
02
Drugs
glutaminecreatine
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT00016653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016653.